Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Integra Lifesciences (IART)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,747,255
  • Shares Outstanding, K 85,229
  • Annual Sales, $ 1,472 M
  • Annual Income, $ 60,800 K
  • 60-Month Beta 0.96
  • Price/Sales 3.24
  • Price/Cash Flow 14.89
  • Price/Book 3.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.61
  • Number of Estimates 8
  • High Estimate 0.63
  • Low Estimate 0.59
  • Prior Year 0.58
  • Growth Rate Est. (year over year) +5.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.68 +10.30%
on 02/20/19
57.31 -2.45%
on 03/13/19
+4.73 (+9.24%)
since 02/19/19
3-Month
42.14 +32.65%
on 01/03/19
57.31 -2.45%
on 03/13/19
+9.33 (+20.03%)
since 12/19/18
52-Week
42.14 +32.65%
on 01/03/19
67.50 -17.19%
on 06/18/18
-0.78 (-1.38%)
since 03/19/18

Most Recent Stories

More News
Integra's Duragen Secures Japanese Nod to Drive Global Growth

Despite facing adverse foreign exchange volatility across its international business, Integra LifeSciences (IART) can successfully eye certain key developments on foreign shores.

ABMD : 336.66 (+1.02%)
PEN : 153.99 (+1.17%)
IART : 56.36 (+1.18%)
MASI : 132.85 (+0.45%)
Integra LifeSciences Announces the Approval of DuraGen(R) in Japan

Integra LifeSciences Holdings Corporation (Nasdaq:IART), a global leader in medical technology, announces the recent approval of DuraGen Dural Regeneration Matrix in Japan. DuraGen is the first and only...

IART : 56.36 (+1.18%)
Integra LifeSciences to participate in Healthcare Conference in March 2019

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in March:

IART : 56.36 (+1.18%)
Integra Rides on Channel Expansion Strategy, New Alliances

Integra's (IART) success with its channel expansion strategy and Codman integration buoys investors' optimism on the stock.

ABMD : 336.66 (+1.02%)
PEN : 153.99 (+1.17%)
IART : 56.36 (+1.18%)
MASI : 132.85 (+0.45%)
Integra's (IART) Q4 Earnings and Revenues Beat Estimates

Strength in the U.S. Codman Specialty Surgical business drives Integra LifeSciences' (IART) top line in Q4.

VAR : 136.76 (+0.88%)
IART : 56.36 (+1.18%)
ANGO : 22.12 (+0.96%)
CNMD : 80.14 (+0.41%)
Integra Lifescie Rises 7.76% on Heavy Volume: Watch For Potential Pullback

Integra Lifescie (NASDAQ:IART) traded in a range yesterday that spanned from a low of $55.42 to a high of $56.46. Yesterday, the shares gained 7.8%, which took the trading range above the 3-day high...

IART : 56.36 (+1.18%)
Integra LifeSciences (IART) Q4 Earnings and Revenues Top Estimates

Integra (IART) delivered earnings and revenue surprises of 4.84% and 0.56%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

IART : 56.36 (+1.18%)
Integra LifeSciences (IART) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Integra (IART) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IART : 56.36 (+1.18%)
Downtrend Call Working As Integra Lifescie Stock Falls 21.0% (IART)

SmarTrend identified a Downtrend for Integra Lifescie (NASDAQ:IART) on October 11th, 2018 at $60.49. In approximately 4 months, Integra Lifescie has returned 21.01% as of today's recent price of $47.78....

IART : 56.36 (+1.18%)
Integra LifeSciences Unveils Titan RSS-S, Widens Portfolio

The latest launch reflects Integra LifeSciences' (IART) consistent efforts to boost the Orthopedics and Tissue Technologies segment.

SRDX : 45.54 (-4.25%)
ATHN : 134.99 (+0.01%)
VEEV : 123.37 (+0.75%)
IART : 56.36 (+1.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More Share

Trade IART with:

Business Summary

Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic surgery, neurosurgery, reconstructive and general surgery. Integra's orthopedic...

See More

Key Turning Points

2nd Resistance Point 56.68
1st Resistance Point 56.19
Last Price 56.36
1st Support Level 55.34
2nd Support Level 54.98

See More

52-Week High 67.50
Fibonacci 61.8% 57.81
Last Price 56.36
Fibonacci 50% 54.82
Fibonacci 38.2% 51.83
52-Week Low 42.14

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar